You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Relapsed ependymoma

Showing 1 - 25 of 5,482
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Medulloblastoma, Glioblastoma Multiforme, Anaplastic Astrocytoma Trial in Buffalo, New York, Cincinnati (SurVaxM for patients

Recruiting
  • Medulloblastoma
  • +7 more
  • SurVaxM for patients with relapsed or progressive MB, HGG or ependymoma ages ≥10 and ≤21 years
  • +2 more
  • Buffalo, New York
  • +2 more
Jul 8, 2022

Glioblastoma, Medulloblastoma, Ependymoma Trial in Augusta, Druid Hills, Boston (Indoximod, Partial Radiation, Full-dose

Recruiting
  • Glioblastoma
  • +3 more
  • Augusta, Georgia
  • +2 more
Aug 18, 2022

Ex Vivo Drug Sensitivity Testing and Mutation Profiling

Completed
  • Recurrent Childhood Acute Myeloid Leukemia
  • +13 more
    • Miami, Florida
      Nicklaus Children's Hospital
    Jan 18, 2023

    Ependymoma, Ewing Sarcoma, High-grade Glioma Trial in Worldwide (Nivolumab, NKTR-214)

    Completed
    • Ependymoma
    • +9 more
    • Nivolumab
    • NKTR-214
    • Little Rock, Arkansas
    • +17 more
    Dec 8, 2022

    CNS Tumors, Atypical Teratoid/Rhabdoid Tumor, Diffuse Midline Glioma, H3 K27M-Mutant Trial in Memphis (B7-H3-CAR T cells)

    Not yet recruiting
    • Central Nervous System Neoplasms
    • +6 more
    • B7-H3-CAR T cells
    • Memphis, Tennessee
      St. Jude Children's Research Hospital
    Apr 18, 2023

    Advanced Malignant Solid Tumor, Recurrent Childhood Ependymoma, Recurrent Ewing Sarcoma Trial in Puerto Rico, United States

    Active, not recruiting
    • Advanced Malignant Solid Neoplasm
    • +31 more
    • Laboratory Biomarker Analysis
    • +2 more
    • Birmingham, Alabama
    • +118 more
    Jan 27, 2023

    Ex Vivo Drug Sensitivity Testing and Multi-Omics Profiling

    Recruiting
    • Recurrent Childhood Acute Myeloid Leukemia
    • +17 more
      • Miami, Florida
        Nicklaus Children's Hospital
      May 13, 2023

      Advanced Malignant Solid Tumor, Ann Arbor Stage III Childhood Non-Hodgkin Lymphoma, Ann Arbor Stage IV Childhood Non-Hodgkin

      Active, not recruiting
      • Advanced Malignant Solid Neoplasm
      • +35 more
      • Birmingham, Alabama
      • +113 more
      Jun 28, 2022

      Advanced Malignant Solid Tumor, Recurrent Ependymoma, Recurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor Trial

      Recruiting
      • Advanced Malignant Solid Neoplasm
      • +30 more
      • Larotrectinib Sulfate
      • Birmingham, Alabama
      • +123 more
      Aug 23, 2022

      Malignant Solid Tumor, Recurrent Ependymoma, Recurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor Trial in Puerto

      Recruiting
      • Malignant Solid Neoplasm
      • +26 more
      • Birmingham, Alabama
      • +121 more
      Aug 24, 2022

      Glioma, Rhabdomyosarcoma, Osteosarcoma Trial (Erlotinib, Temozolomide)

      Withdrawn
      • Glioma
      • +7 more
      • (no location specified)
      Sep 5, 2019

      Brain Metastasis, Spinal Tumors, Lung Tumors Trial in France (SBRT treatment)

      Completed
      • Brain Metastasis
      • +3 more
      • SBRT treatment
      • Nice, Alpes Maritimes, France
      • +14 more
      Mar 7, 2022

      Tumors Trial in Cincinnati, Columbus (BXQ-350)

      Terminated
      • Neoplasms
      • Cincinnati, Ohio
      • +1 more
      Jul 21, 2021

      CNS Tumor, Pediatric, Glioma, Ependymoma Trial in Seattle (EGFR806-specific chimeric antigen receptor (CAR) T cell)

      Active, not recruiting
      • Central Nervous System Tumor, Pediatric
      • +8 more
      • EGFR806-specific chimeric antigen receptor (CAR) T cell
      • Seattle, Washington
        Seattle Children's Hospital
      Jan 18, 2023

      Advanced Malignant Solid Tumor, Ann Arbor Stage III Non-Hodgkin Lymphoma, Ann Arbor Stage IV Non-Hodgkin Lymphoma Trial in

      Recruiting
      • Advanced Malignant Solid Neoplasm
      • +32 more
      • Laboratory Biomarker Analysis
      • +2 more
      • Birmingham, Alabama
      • +124 more
      Aug 24, 2022

      Glioma Trial in United States (ONC201)

      Active, not recruiting
      • Glioma
      • San Francisco, California
      • +8 more
      Jul 14, 2022

      CNS Tumor, Pediatric, Glioma, Ependymoma Trial in Seattle (HER2-specific chimeric antigen receptor (CAR) T cell)

      Recruiting
      • Central Nervous System Tumor, Pediatric
      • +8 more
      • HER2-specific chimeric antigen receptor (CAR) T cell
      • Seattle, Washington
        Seattle Children's Hospital
      Dec 14, 2022

      Pediatric Solid Tumor, Pediatric Lymphoma, Pediatric Brain Tumor Trial in Australia, Canada, United States (CLR 131)

      Recruiting
      • Pediatric Solid Tumor
      • +7 more
      • CLR 131
      • Palo Alto, California
      • +6 more
      Nov 30, 2021

      Advanced Malignant Solid Tumor, Ann Arbor Stage III Non-Hodgkin Lymphoma, Ann Arbor Stage IV Non-Hodgkin Lymphoma Trial in

      Recruiting
      • Advanced Malignant Solid Neoplasm
      • +44 more
      • Biopsy
      • +23 more
      • Birmingham, Alabama
      • +166 more
      Feb 2, 2023

      Posterior Fossa Ependymoma (PFEPN) Trial in Aurora (Trastuzumab after SubQ GM-CSF, Trastuzumab in combination with SubQ GM-CSF)

      Recruiting
      • Posterior Fossa Ependymoma (PFEPN)
      • Trastuzumab after SubQ GM-CSF
      • Trastuzumab in combination with SubQ GM-CSF
      • Aurora, Colorado
        Children's Hospital Colorado
      Dec 2, 2021

      Cancer Trial in United States (Sirolimus, Celecoxib, Etoposide)

      Recruiting
      • Cancer
      • Phoenix, Arizona
      • +5 more
      Oct 28, 2021

      Advanced Malignant Solid Tumor, Recurrent Ependymal Tumor, Recurrent Ewing Sarcoma Trial in Puerto Rico, United States

      Active, not recruiting
      • Advanced Malignant Solid Neoplasm
      • +35 more
      • Birmingham, Alabama
      • +108 more
      Oct 19, 2022

      Ependymoma Trial in Houston (Antineoplaston therapy (Atengenal + Astugenal))

      Terminated
      Has Results
      • Ependymoma
      • Antineoplaston therapy (Atengenal + Astugenal)
      • Houston, Texas
        Burzynski Clinic
      Feb 18, 2022

      Relapsed Solid Tumor, Refractory Solid Tumor Trial in Worldwide (Abemaciclib, Irinotecan, Temozolomide)

      Recruiting
      • Relapsed Solid Tumor
      • Refractory Solid Tumor
      • Phoenix, Arizona
      • +28 more
      Dec 7, 2022

      Ependymoma, Recurrent Childhood, Ependymoma Trial in Denver, Orlando (Granulocyte Macrophage Colony Stimulation Factor)

      Active, not recruiting
      • Ependymoma, Recurrent Childhood
      • Ependymoma
      • Granulocyte Macrophage Colony Stimulation Factor
      • Denver, Colorado
      • +1 more
      Feb 8, 2022